Showing results (381-390 of 502) with videos related to

Sort By:
Pageof 51
JACC. Cardiovascular Interventions|October 21, 2019
Dedicated Closure Device for Transcaval Access Closure: From Concept to First-in-Human TestingToby Rogers, Adam B Greenbaum, Vasilis C Babaliaros, et al.
The American Journal of Cardiology|December 28, 2010
Effect of insurance type on adverse cardiac events after percutaneous coronary interventionMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
American Heart Journal|June 24, 2010
Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?Cédric Delhaye, Kohei Wakabayashi, Gabriel Maluenda, et al.
The American Journal of Cardiology|October 6, 2009
Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Itsik Ben-Dor, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 20, 2022
The Clinical Profile and Natural History of Patients Who Fail Screening for Transcatheter Mitral Valve Replacement: Rationale and Design of the Prospective Multicenter Mitral Valve Screening Survey (MVSS)Giorgio A Medranda, Toby Rogers, Thomas Modine, et al.
The American Journal of Cardiology|September 1, 2020
Procedural Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention During Normal Work Hours Versus Non-work HoursBrian C Case, Charan T Yerasi, Brian J Forrestal, et al.
The American Journal of Cardiology|August 13, 2021
Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 PandemicBrian C Case, Jonathan Abramowitz, Corey Shea, et al.
Lancet (London, England)|October 27, 2004
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyEugène P McFadden, Eugenio Stabile, Evelyn Regar, et al.
Pageof 51